Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Everett

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.
JACC. Basic to Translational Science|March 13, 2023
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR TrialViviany R Taqueti, Amil M Shah, Brendan M Everett, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
Annals of Internal Medicine|March 20, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 HospitalizationTracy Y Wang, Abdus S Wahed, Alison Morris, et al.
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
Journal of the American College of Cardiology|February 4, 2014
Novel genetic markers associate with atrial fibrillation risk in Europeans and JapaneseSteven A Lubitz, Kathryn L Lunetta, Honghuang Lin, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
Transfusion Medicine Reviews|May 28, 2013
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trialVipul Jairath, Brennan C Kahan, Alasdair Gray, et al.
The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.
JACC. Basic to Translational Science|March 13, 2023
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR TrialViviany R Taqueti, Amil M Shah, Brendan M Everett, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
Annals of Internal Medicine|March 20, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 HospitalizationTracy Y Wang, Abdus S Wahed, Alison Morris, et al.
The New England Journal of Medicine|November 7, 2022
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskAruna Das Pradhan, Robert J Glynn, Jean-Charles Fruchart, et al.
Journal of the American College of Cardiology|February 4, 2014
Novel genetic markers associate with atrial fibrillation risk in Europeans and JapaneseSteven A Lubitz, Kathryn L Lunetta, Honghuang Lin, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
Pageof 37